ARCHIVES

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

House Members Express Support for Cancer Program

September 12, 1980

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

In Brief: Whittaker Corp, Trying To Hire NCI Director; Environmental Carcinogenesis On NCAB Agenda

February 13, 1976

NCCS Selects New President

October 9, 2009